In hepatocellular carcinoma and glioblastoma, upregulation of IGF2BP3 increased c-Myc expression and activated PI3K-AKT pathway, thereby affecting cell proliferation, cell cycle, and apoptosis (40, 41). The gene discussed is IGF2BP3; the disease is hepatocellular carcinoma.